ResMed third-quarter profit drops 3pc to $US88.5m
Tim BinstedReporter
Updated
ResMed chief executive Mick Farrell said the medical device maker is only one mile into a marathon in its push to integrate data and cloud technology with healthcare.
In February the $10.6 billion ResMed inked a deal to acquire health information technology group Brightree for $US800 million in a clear signal of strategic intent.
Loading...
Tim Binsted writes on Business specialising in Agriculture, Construction, Manufacturing. Tim is based in our Sydney newsroom. Connect with Tim on Twitter.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Equity markets
Fetching latest articles